Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shridhar Bale

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Plos Pathogens|October 3, 2012
Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonismShridhar Bale, Jean-Philippe Julien, Zachary A Bornholdt, et al.
Frontiers in Immunology|June 9, 2018
Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing AntibodiesShridhar Bale, Alexandra Martiné, Richard Wilson, et al.
Nature Communications|May 18, 2018
Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimerAnita Sarkar, Shridhar Bale, Anna-Janina Behrens, et al.
Nature Structural & Molecular Biology|November 22, 2011
A shared structural solution for neutralizing ebolavirusesJoão M Dias, Ana I Kuehne, Dafna M Abelson, et al.
Frontiers in Immunology|August 9, 2024
mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodiesJavier Guenaga, Mehrdad Alirezaei, Yu Feng, et al.
Immunity|May 18, 2017
Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap ApproachPaola Martinez-Murillo, Karen Tran, Javier Guenaga, et al.
NPJ Vaccines|August 20, 2025
Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysisShridhar Bale, Elena Gustchina, Javier Guenaga, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
HIV Env trimers elicit NHP apex cross-neutralizing antibodies mimicking human bNAbsJavier Guenaga, Monika Adori, Shridhar Bale, et al.
Nature|April 29, 2026
Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apexJavier Guenaga, Monika Ádori, Shridhar Bale, et al.
Nature Communications|December 22, 2025
Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement riskYimeng Wang, Andrey Galkin, Xiaoran Shang, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Plos Pathogens|October 3, 2012
Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonismShridhar Bale, Jean-Philippe Julien, Zachary A Bornholdt, et al.
Frontiers in Immunology|June 9, 2018
Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing AntibodiesShridhar Bale, Alexandra Martiné, Richard Wilson, et al.
Nature Communications|May 18, 2018
Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimerAnita Sarkar, Shridhar Bale, Anna-Janina Behrens, et al.
Nature Structural & Molecular Biology|November 22, 2011
A shared structural solution for neutralizing ebolavirusesJoão M Dias, Ana I Kuehne, Dafna M Abelson, et al.
Frontiers in Immunology|August 9, 2024
mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodiesJavier Guenaga, Mehrdad Alirezaei, Yu Feng, et al.
Immunity|May 18, 2017
Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap ApproachPaola Martinez-Murillo, Karen Tran, Javier Guenaga, et al.
NPJ Vaccines|August 20, 2025
Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysisShridhar Bale, Elena Gustchina, Javier Guenaga, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
HIV Env trimers elicit NHP apex cross-neutralizing antibodies mimicking human bNAbsJavier Guenaga, Monika Adori, Shridhar Bale, et al.
Nature|April 29, 2026
Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apexJavier Guenaga, Monika Ádori, Shridhar Bale, et al.
Nature Communications|December 22, 2025
Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement riskYimeng Wang, Andrey Galkin, Xiaoran Shang, et al.
Pageof 4